Haris Babačić

Publikationer
CV
Populärvetenskap och samverkan

Artiklar

Article: NATURE COMMUNICATIONS. 2023;14(1):5921
Comprehensive proteomics and meta-analysis of COVID-19 host response
Babacic H; Christ W; Araujo JE; Mermelekas G; Sharma N; Tynell J; Garcia M; Varnaite R; Asgeirsson H; Glans H; Lehtioe J; Gredmark-Russ S; Klingstroem J; Pernemalm M
Article: RESPIRATORY RESEARCH. 2023;24(1):62
Targeted plasma proteomics reveals signatures discriminating COVID-19 from sepsis with pneumonia
Palma Medina LM; Babacic H; Dzidic M; Parke A; Garcia M; Maleki KT; Unge C; Lourda M; Kvedaraite E; Chen P; Muvva JR; Cornillet M; Emgard J; Moll K; Michaelsson J; Flodstrom-Tullberg M; Brighenti S; Buggert M; Mjosberg J; Malmberg K-JK; Sandberg J; Gredmark-Russ S; Rooyackers O; Svensson MJ; Chambers BI; Eriksson L; Pernemalm MK; Bjorkstrom N; Aleman S; Ljunggren H-G; Klingstrom J; Stralin K; Norrby-Teglund A
Article: MOLECULAR ONCOLOGY. 2023;17(2):238-260
Glioblastoma stem cells express non-canonical proteins and exclusive mesenchymal-like or non-mesenchymal-like protein signatures
Babacic H; Galardi S; Umer HM; Hellstrom M; Uhrbom L; Maturi N; Cardinali D; Pellegatta S; Michienzi A; Trevisi G; Mangiola A; Lehtio J; Ciafre SA; Pernemalm M
Article: NEOPLASIA. 2021;23(8):783-791
Plasma proteome alterations by MAPK inhibitors in BRAF^V600-mutated metastatic cutaneous melanoma
Babacic H; Eriksson H; Pernemalm M
Article: JOURNAL FOR IMMUNOTHERAPY OF CANCER. 2020;8(1):e000204
In-depth plasma proteomics reveals increase in circulating PD-1 during anti-PD-1 immunotherapy in patients with metastatic cutaneous melanoma
Babacic H; Lehtio J; de Coana YP; Pernemalm M; Eriksson H
Article: JOURNAL OF NEUROLOGY. 2019;266(6):1358-1366
Evaluating the diagnostic utility of new line immunoassays for myositis antibodies in clinical practice: a retrospective study
Montagnese F; Babacic H; Eichhorn P; Schoser B
Article: JOURNAL OF NEUROLOGY. 2019;266(1):133-147
Safety and efficacy of short- and long-term inspiratory muscle training in late-onset Pompe disease (LOPD): a pilot study
Wenninger S; Greckl E; Babacic H; Stahl K; Schoser B
Article: JOURNAL OF NEUROMUSCULAR DISEASES. 2018;5(4):451-459
How to Interpret Abnormal Findings of Spirometry and Manometry in Myotonic Dystrophies?
Babačić H; Goldina O; Stahl K; Montagnese F; Jurinović V; Schoser B; Wenninger S
Article: MULTIPLE SCLEROSIS AND RELATED DISORDERS. 2018;25:112-121
The disease burden of Multiple Sclerosis from the individual and population perspective: Which symptoms matter most?
Barin L; Salmen A; Disanto G; Babacic H; Calabrese P; Chan A; Kamm CP; Kesselring J; Kuhle J; Gobbi C; Pot C; Puhan MA; von Wyl V
Article: NEUROMUSCULAR DISORDERS. 2018;28(3):229-235
Falls and resulting fractures in Myotonic Dystrophy: Results from a multinational retrospective survey
Jimenez-Moreno AC; Raaphorst J; Babacic H; Wood L; van Engelen B; Lochmueller H; Schoser B; Wenninger S

Alla övriga publikationer

Thesis / dissertation: 2023
Discovering circulating protein biomarkers through in-depth plasma proteomics
Babačić, Haris
Preprint: BIORXIV. 2022
Glioblastoma stem cells express non-canonical proteins and exclusive mesenchymal-like or non-mesenchymal-like protein signatures
Babačić H; Galardi S; Umer HM; Cardinali D; Pellegatta S; Hellström M; Uhrbom L; Maturi N; Michienzi A; Trevisi G; Mangiola A; Lehtiö J; Ciafrè SA; Pernemalm M
Letter: ALLERGY. 2022;77(1):296-298
A single dose of BNT162b2 vaccine elicits strong humoral response in SARS-CoV-2 seropositive individuals
Blazhevska TB; Babacic H; Sibinovska O; Dobrevski B; Kirijas M; Milanovski G; Arsov T; Petlichkovski A
Meeting abstract: ANNALS OF ONCOLOGY. 2020;31:S760
Plasma proteomics in patients with metastatic cutaneous melanoma treated with targeted therapy
Eriksson H; Babacic H; Lehtio J; Pernemalm M
Preprint: MEDRXIV. 2020
Global between-countries variance in SARS-CoV-2 mortality is driven by reported prevalence, age distribution, and case detection rate
Babačić H; Lehtiö J; Pernemalm M
Meeting abstract: JOURNAL OF CLINICAL ONCOLOGY. 2019;37(15):9574
Plasma proteomic analyses and treatment predictive biomarker candidates in melanoma patients receiving immune checkpoint blockade or targeted therapy.
Eriksson H; Babacic H; Lehtio J; Pernemalm M
Conference publication: NERVENHEILKUNDE. 2019;38(05):286-287
Diagnostische Relevanz von Myositis-Antikörpern in der neuromuskulären Ambulanz: eine retrospektive Studie
Montagnese F; Babacic H; Eichhorn P; Schoser B
Review: PLOS ONE. 2019;14(2):e0212198
CRISPR-cas gene-editing as plausible treatment of neuromuscular and nucleotide-repeat-expansion diseases: A systematic review
Babacic H; Mehta A; Merkel O; Schoser B
Conference publication: NEUROMUSCULAR DISORDERS. 2018;28:S137
Safety and efficacy of recurrent inspiratory muscle training in late onset Pompe disease
Wenninger S; Greckl E; Babacic H; Schoser B

Anställningar

Postdoktor, Onkologi-Patologi, Karolinska Institutet, 2023-2025

Examina och utbildning

Medicine Doktorsexamen, Institutionen för onkologi-patologi, Karolinska Institutet, 2023
Master of Science in Epidemiology, Institute for Medical Information Processing, Biometry, and Epidemiology, Ludwig-Maximilians-Universität München, 2017
Doctor of Medicine, Faculty of Medicine, Saints Cyril and Methodius University of Skopje, 2015

Artiklar

Alla övriga publikationer

Anställningar

Examina och utbildning

Nyheter från KI

Kalenderhändelser från KI